Corrado Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-29,547
| Closed | -$61K | – | 99 |
|
|
2018
Q3 | $61K | Sell |
29,547
-15,344
| -34% | -$31.7K | 0.04% | 99 |
|
|
2018
Q2 | $80K | Hold |
44,891
| – | – | 0.05% | 105 |
|
|
2018
Q1 | $106K | Sell |
44,891
-40,691
| -48% | -$96.1K | 0.06% | 114 |
|
|
2017
Q4 | $161K | Buy |
85,582
+1,143
| +1% | +$2.15K | 0.09% | 110 |
|
|
2017
Q3 | $210K | Buy |
84,439
+13,716
| +19% | +$34.1K | 0.12% | 106 |
|
|
2017
Q2 | $195K | Hold |
70,723
| – | – | 0.11% | 105 |
|
|
2017
Q1 | $213K | Buy |
70,723
+32,090
| +83% | +$96.6K | 0.12% | 97 |
|
|
2016
Q4 | $122K | Buy |
38,633
+2,286
| +6% | +$7.22K | 0.08% | 102 |
|
|
2016
Q3 | $124K | Buy |
+36,347
| New | +$124K | 0.08% | 99 |
|